{"nct_id":"NCT03284957","title":"Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer","status":"TERMINATED","status_verified_date":"2024-12","start_date":"2017-09-20","start_date_type":"ACTUAL","primary_completion_date":"2024-11-08","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["SNY"]}